CoChat

Aging, Metabolism, Synaptic Activity, and Aβ in Alzheimer's Disease

Gouras, Gunnar K. · 2019 · Frontiers in Aging Neuroscience
Cited by 10

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnagi.2019.00185

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 14

  1. Bateman, 2012, Clinical and biomarker changes in dominantly inherited Alzheimer's disease, N. Engl. J. Med., 367795, 10.1056/NEJMoa1202753 · DOI · Paper page
  2. Buchhave, 2012, Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia, Arch. Gen. Psychiatry, 69, 98, 10.1001/archgenpsychiatry.2011.155 · DOI · Paper page
  3. Cataldo, 2000, Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am. J. Pathol., 157, 277, 10.1016/S0002-9440(10)64538-5 · DOI · Paper page
  4. DeKosky, 1990, Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity, Ann. Neurol., 27, 457, 10.1002/ana.410270502 · DOI · Paper page
  5. Guimas Almeida, 2018, Impact of late-onset Alzheimer's genetic risk factors on β-amyloid endocytic production, Cell. Mol. Life Sci, 75, 2577, 10.1007/s00018-018-2825-9 · DOI
  6. Kobro-Flatmoen, 2016, Reelin-immunoreactive neurons in entorhinal cortex layer II selectively express intracellular amyloid in early Alzheimer's disease, Neurobiol. Dis., 93, 172, 10.1016/j.nbd.2016.05.012 · DOI · Paper page
  7. Li, 2004, Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice, J. Neurochem, 89, 1308, 10.1111/j.1471-4159.2004.02455.x · DOI · Paper page
  8. Melnikova, 2013, Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis, J. Neurosci., 33, 3765, 10.1523/JNEUROSCI.4251-12.2013 · DOI
  9. Mohajeri, 2002, Passive immunization against β-amyloid peptide protects central nervous system (CNS) neurons from increased vulnerability associated with an Alzheimer's disease-causing mutation, J. Biol. Chem., 277, 33012, 10.1074/jbc.M203193200 · DOI · Paper page
  10. Small, 2017, Endosomal traffic jams represent a pathogenic hub and therapeutic target in Alzheimer's disease, Trends Neurosci., 40, 592, 10.1016/j.tins.2017.08.003 · DOI · Paper page
  11. Tampellini, 2010, Effects of synaptic modulation on β-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice, J. Neurosci, 30, 14299, 10.1523/JNEUROSCI.3383-10.2010 · DOI · Paper page
  12. Thal, 2002, Phases of Aβ-deposition in the human brain and its relevance for the development of AD, Neurology, 58, 1791, 10.1212/WNL.58.12.1791 · DOI · Paper page
  13. Wang, 2019, Therapeutic potential of AMP-activated protein kinase in Alzheimer's disease, J. Alzheimers. Dis., 68, 33, 10.3233/JAD-181043 · DOI
  14. Welikovitch, 2018, Evidence of intraneuronal Aβ accumulation preceding tau pathology in the entorhinal cortex, Acta Neuropathol, 136, 901, 10.1007/s00401-018-1922-z · DOI

Metadata

Authors
Gouras, G. K.
Venue
Frontiers in Aging Neuroscience
Published
2019-07-23
Volume
11
ISSN
1663-4365
Cited by
10
References
18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.